Product Banner

Cancer Screening Market in India (2018-2023)

Cancer Screening Market in India (2018-2023)
$1,199.00
$1,199.00
  • Sep 19, 2018
  • 75-90 pages
  • Netscribes
Abstract
Cancer screening market in India

The Asia-Pacific is a growing region and holds lots of positive socio-economic factors suitable for the growth and progress of the market primarily because of its association with the global value chains (GVCs). India being a part of the Asia-Pacific region, holds key access to the region's close association with trade agreements with global growth centers. The total market for diagnostic and medical equipment in India is worth USD 14.73 billion and is forecasted to expand at an annual rate of 13% CAGR during the forecast period 2018-2023.

Key growth factors

With the growing population, the cancer burden continues to grow in India. Hence, arises the need of more precision based medical technologies and methodologies to cater to the need of the region.

Threats and key players

Though the Indian market is burgeoning with opportunities .It needs to focus more on its tax regime and easier business conditions. More than 1 million cases of cancer are diagnosed in India every year and this number is bound to increase by 5 billion. Taking into considerations the risks, the region is bound to encounter human and economic costs from the increasing rate of cancer.
The key players operating in the cancer screening market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Siemens Healthineers, Philips and GE Healthcare.

What is covered in the report?

1. Overview of the cancer screening market in India.
2. Market drivers and challenges in the cancer screening market in India.
3. Market trends in the cancer screening market in India.
4. Historical, current and forecasted market size data for segments based on end users (hospitals, laboratories, and independent physicians and clinics).
5. Historical, current and forecasted market size data for segments based on screening type (Laboratory, genetic, biopsy, imaging and endoscopy testing).
6. Historical, current and forecasted market size data for segmentation based on application type (lung, breast, melanoma, kidney and colorectal cancer).
7. Analysis of the competitive landscape and profiles of the major companies operating in the market.

Why buy?

o Understand the demand for cancer screening market in India to determine the viability of the market.
o Identify the developed and emerging markets where cancer screening market in India is sold.
o Identify the challenge areas and address them.
o Develop strategies based on the drivers, trends and highlights for each of the segments.
o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed.
o Recognize the key competitors of this market and respond accordingly.
o Knowledge of the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth.
o Define the competitive positioning by comparing the products and services with the key players in the market.

Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at support@researchonglobalmarkets.com.
Table of Contents
Chapter 1: Executive summary

1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary

Chapter 2: Cancer screening market in India - market overview

2.1. India market overview - market trends, market attractiveness analysis, geography-wise market revenue (USD)
2.2. India - market drivers and challenges
2.3. Value chain analysis - industrial valve market in India
2.4. Porter's five forces analysis

Chapter 3. Cancer screening market in India - by end users

3.1. Hospitals - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.2. Laboratories - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
3.3. Independent physicians and clinics - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 4. Cancer screening market in India - by screening type

4.1. Laboratory testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.2. Genetic testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.3. Imaging testing - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.4. Biopsy testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
4.5. Endoscopy testing- Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 5. Cancer screening market in India - by application

5.1. Lung cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.2. Breast cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.3. Melanoma cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.4. Kidney cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations
5.5. Colorectal cancer - Historical (2015-2017) and forecasted (2018-2023) market size (USD Bn), key observations

Chapter 6: Competitive landscape

6.1. F. Hoffmann-La Roche AG (*)
6.1. a. Company snapshot
6.1. b. Product offerings
6.1. c. Growth strategies
6.1. d. Initiatives
6.1. e. Geographical presence
6.1. f. Key numbers
6.2. GlaxoSmithKline PLC
6.3. Siemens Healthineers
6.4. Philips
6.5. GE Healthcare
(*) all the information are similar for the mentioned companies

Chapter 7: Conclusion

Chapter 8: Appendix

8.1. List of tables
8.2. Assumptions
8.3. Research and methodology
8.4. About Netscribes Inc.

Note: The Table of Contents (Toc) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research. Disclaimer: The report will be delivered within 5-7 business days post payment confirmation
List of Figures
List of Tables
Companies Covered
1. F. Hoffmann-La Roche AG
2. GlaxoSmithKline PLC
3. Siemens Healthineers
4. Philips
5. GE Healthcare